announcements

2008/2007 | 2006 | 2005 | 2004 | 2003

2008

Cytopia strengthens scientific team with US based drug
development specialist
10 July 2008

Cytopia to present data on FMS Program with Anticancer potential
18 June 2008

Release of Cytopia Abstract for CYT997 at Oral Presentation at ASCO
16 May 2008

Novel Anti-Cancer Drug Development Collaboration
8 May 2008

CyTopics - April 2008 Edition
21 April 2008

Cytopia Presentation on JAK2
9 April 2008

CYT Clinical Trial Update
28 March 2008

Cytopia nominates JAK2 clinical candidate for myeloproliferative disorders
18 March 2008

Anti-cancer Drug CYT997 Update
13 March 2008

Cytopia Half Year Report: Clinical Development Accelerates In 2008
8 February 2008

Appendix 3b
8 February 2008

Cytopia JAK2 inhibitor shows potent activity in cells from MPD patients
30 January 2008

2007

APP 3B - Share Placement
20 December 2007

Section 708A Notice
20 December 2007

Share Placement
14 December 2007

Trading Halt
12 December 2007

Cytopia Commences Phase II Cancer Drug Study
3 December 2007

Final Director's Interest Notice
22 November 2007

CYT997 Presentation to AGM
16 November 2007

Appendix 3B
16 November 2007

Retirement of Director
15 November 2007

Results of Meeting
15 November 2007

Chairman's Address to Shareholders
15 November 2007

Cytopia reports Final Data from Phase I Cancer Trial
13 November 2007

Appointment of new CFO and Company Secretary
29 October 2007

Phase II Trial in Multiple Myeloma to begin end 2007
17 October 2007

Cytopia Annual Report 2007
12 October 2007

Notice of Annual General Meeting/Proxy Form
12 October 2007

Cytopia compounds show potentials as treatment for bone loss
13 September 2007

Change of Pooled Development Fund Status
17 August 2007

Presentation - Broker Briefing
15 August 2007

Financial Report / Full Year Accounts
13 August 2007

Phase I Intravenous Trial Achieves Primary Objectives
9 August 2007

Presentation to Australian Bio-Investment Forum
11 July 2007

Cytopia Strengthens Cancer Clinical Trial with New Site
11 July 2007

Appendix 3B
29 June 2007

Relinquishment of Pooled Development Fund ("PDF") Registration
22 June 2007

Formation of Clinical Advisory Panel
31 May 2007

Clinical Trial Progress of Cancer Drug CYT997
17 May 2007

Presentation to US Bio-Investment Forum
2 May 2007

Presentation at Lodge Partners Mid Cap Confab
28 March 2007

Cytopia Half Year Report to 31 December 2006
9 February 2007